Pfizer (PFE) Tops Q1 EPS by 10c; Bumps EPS Outlook
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $28.07 +0.50%
Revenue Growth %: -4.6%
Financial Fact:
Net income before allocation to noncontrolling interests: 1.32B
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -4.6%
Financial Fact:
Net income before allocation to noncontrolling interests: 1.32B
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q1 EPS of $0.85, $0.10 better than the analyst estimate of $0.75. Revenue for the quarter came in at $13.1 billion versus the consensus estimate of $12.99 billion.
GUIDANCE:
Pfizer raises midpoint of FY2019 EPS by 1 cent to $2.83-$2.93, versus the consensus of $2.89. Reaffirmed 2019 Financial Guidance for Revenues
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Interactive Strength reports record Q2 results, raises Q3 guidance
- Citi expects Micron stock to rally into this event
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
